María-José Calasanz (Maria J Calasanz, M J Calasanz, María José Calasanz, María J Calasanz, Maria-Jose Calasanz, Maria José Calasanz)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Histone Deacetylase

Ejection Fraction

Top Venues

Blood cancer journal

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Juan José Lahuerta, María-José Calasanz
RASping myeloma genomics. Blood 144 (2) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Ana Guijarro-Hernández, Cristina Hurtado, María José Larráyoz, María-José Calasanz, José Luis Vizmanos
CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia. Cancers 16 (8) (2024)
A Medina-Herrera, I Vazquez, I Cuenca, J M Rosa-Rosa, Beñat Ariceta, C Jimenez, M Fernandez-Mercado, M J Larrayoz, N C Gutierrez, M Fernandez-Guijarro, Verónica González De La Calle, Paula Rodriguez Otero, A Oriol, Laura Rosinol, A Alegre, F Escalante, Javier de la Rubia, A I Teruel, Felipe De Arriba, Miguel-Teodoro T Hernandez Garcia, Javier López Jiménez, E M Ocio, N Puig, Juan José Lahuerta, Juan-José Lahuerta, Joan Bladé, Jesús San F Miguel, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, null null
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal 14 (1) (2024)
Ana Guijarro-Hernández, Cristina Hurtado, María José Larráyoz, María-José Calasanz, José Luis Vizmanos
CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia. Cancers 16 (8) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Claudia Sargas, Rosa María Ayala, María J Larráyoz, María C Chillón, Eduardo Rodríguez Arbolí, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan-Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María T Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null null
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group. Blood cancer journal 13 (1) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Catia Simoes, Sara Villar, Beñat Ariceta, Juan-José Garcés, Leire Burgos, Diego Alignani, Sarai Sarvide, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez-Lorenzo, Maria-Belen Vidriales, Carmen Chillon, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa María Ayala, Joaquin Martinez Lopez, Ana Alfonso Pierola, María-José Calasanz, Felipe Prosper, Jesús San F Miguel, Miguel Á Sanz, Juan José Lahuerta, Pau Montesinos, null null
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia. British journal of haematology (2023)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, María-José Calasanz, Norma C Gutiérrez, Manuela Fernandez, Albert Ortiol, Rafael Rios-Tamayo, Miguel-Teodoro T Hernandez Garcia, Rafael Martínez-Martínez, Joan Bargay, Felipe de Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Marta-Sonia Gonzalez Perez, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez-Lopez, Laura Rosinol, Joan Bladé, Juan-José Lahuerta, Jesús San F Miguel, Juan José Lahuerta
Predictors of unsustained measurable residual disease negativity in transplant-eligible multiple myeloma patients. Blood (2023)
Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay, Amaia Etxebeste, Maddalen Jimenez, Cristina Perez, Raquel Ordoñez, César Cobaleda, Cirino Botta, Vicente Jose Fresquet, Sergio Roa, Ibai Goicoechea, Catarina Maia, Miren Lasaga, Marta Chesi, Peter Leif Bergsagel, Maria J Larrayoz, María-José Calasanz, Elena Campos-Sanchez, Jorge Martinez-Cano, Carlos Panizo, Paula Rodriguez-Otero, Silvestre Vincent, Giovanna Roncador, Patricia Gonzalez, Satoru Takahashi, Samuel G Katz, Loren D Walensky, Shannon M Ruppert, Elisabeth A Lasater, Maria Amann, Teresa Lozano, Diana Llopiz, Pablo Sarobe, Juan Jose Lasarte, Nuria Planell, David Gomez-Cabrero, Olga Mikhaylovna Plotnikova, Anna Kurilovich, Maria Victoria Revuelta, Leandro Cerchietti, Xabier Agirre, Jesús San F Miguel, Juan José Lahuerta, Felipe Prosper, Jose-Angel Martinez-Climent
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma. Nature medicine 29 (3) (2023)
Juan José Lahuerta, María-José Calasanz
Highs and lows of t(4;14) in multiple myeloma. Blood 141 (13) (2023)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Juan-José Garcés, María-Teresa Cedena, Noemi Puig, Leire Burgos, Jose J Perez, Lourdes Cordon, Juan A Flores-Montero, Luzalba Sanoja-Flores, María-José Calasanz, Albert Ortiol, María-Jesús Blanchard, Rafael Rios-Tamayo, Jesús Martín-Sánchez, Rafael Martínez-Martinez, Joan Bargay, Anna Sureda, Javier de la Rubia, Miguel-Teodoro T Hernandez Garcia, Paula Rodriguez Otero, Javier de la Cruz, Alberto Orfao, Maria-Victoria Mateos-Manteca, Joaquin Martinez Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Jesús San F Miguel, Juan José Lahuerta
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Silvia Ramos-Campoy, Anna Puiggros, Joanna Kamaso, Sílvia Beà, Sandrine Bougeon, María José Larráyoz, Dolors Costa, Helen Parker, Gian Matteo Rigolin, María Laura Blanco, Rosa Collado, Idoya Ancín, Rocío Salgado, Marco A Moro-García, Tycho Baumann, Eva Gimeno, Carol Moreno, Marta Salido, Xavier Calvo, María-José Calasanz, Antonio Cuneo, Florence Nguyen-Khac, David Oscier, Claudia Haferlach, Jonathan C Strefford, Jacqueline Schoumans, Blanca Espinet
TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype. Cancers 14 (15) (2022)
Juan Manuel Rosa-Rosa, Isabel Cuenca, Alejandro Medina, Iria Vazquez, Andrea Sánchez-delaCruz, Natalia Buenache, Ricardo Sanchez, Cristina Jiménez, Laura Rosinol, Norma C Gutiérrez, Yanira Ruiz-Heredia, Santiago Barrio, Albert Oriol, Maria-Luisa Martin-Ramos, María-Jesús Blanchard, Rosa María Ayala, Rafael Ríos-Tamayo, Anna Sureda, Miguel-Teodoro Hernández, Javier de la Rubia, Gorka Alkorta-Aranburu, Xabier Agirre, Joan Bladé, Maria-Victoria Mateos-Manteca, Juan-José Lahuerta, Jesús F San-Miguel, María-José Calasanz, Miriam Santero, Joaquín Martínez-Lopez
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial. Cancers 14 (20) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Catia Simoes, Maria Carmen Chillon, David Martínez-Cuadrón, María-José Calasanz, María-Belén Vidriales, Iria Vazquez, Montserrat Hernández-Ruano, Beñat Ariceta, Paula Aguirre-Ruiz, Leire Burgos, Diego Alignani, Sarai Sarvide, Sara Villar, Ana Alfonso, Felipe Prosper, Rosa María Ayala, Joaquin Martínez-López, Juan-Miguel Bergua, Susana Vives, Jose Antonio Perez-Simon, María García-Fortes, Teresa Bernal Del Castillo, Mercedes Colorado, Mayte Olave, Juan I Rodríguez-Gutiérrez, Jorge Labrador, Marcos González-Díaz, Jesús San F Miguel, Miguel A Sanz, Pau Montesinos, Juan José Lahuerta
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia. Blood advances (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Sara Rodriguez, Jon Celay, Ibai Goicoechea, Cristina Jiménez, Cirino Botta, Maria-José Garcia-Barchino, Juan-José Garcés, Marta Larrayoz, Susana Santos, Diego Alignani, Amaia Vilas-Zornoza, Cristina Perez, Sonia Garate, Sarai Sarvide, Aitziber Lopez, Hans-Christian Reinhardt, Yolanda R Carrasco, Isidro Sanchez-Garcia, Maria-Jose Larrayoz, María-José Calasanz, Carlos Panizo, Felipe Prosper, José María Lamo-Espinosa, Marina Motta, Alessandra Tucci, Antonio Sacco, Massimo Gentile, Sara Duarte, Helena Vitoria, Catarina Geraldes, Artur Paiva, Noemi Puig, Miriam Santero, Aldo M Roccaro, Gema Fuerte, Jesús San F Miguel, Jose-Angel Martinez-Climent, Juan José Lahuerta
Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma. Science advances 8 (3) (2022)
David Martínez-Cuadrón, Josefina Serrano, José Mário Mariz, Cristina Gil, Mar Tormo, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Raimundo García-Boyero, Carlos Rodríguez-Medina, Carmen Martínez-Chamorro, Marta Polo, Juan Bergua, Eliana Aguiar, María L Amigo, Pilar Herrera, Juan Manuel Alonso-Domínguez, Teresa Bernal Del Castillo, Ana Espadana, María J Sayas, Lorenzo Algarra, Maria Vidriales Vicente, Graça Vasconcelos, Susana Vives, Manuel Mateo Pérez Encinas, Aurelio López, Víctor Noriega, María García-Fortes, María C Chillón, Juan I Rodríguez-Gutiérrez, María-José Calasanz, Jorge Labrador-Gomez, Juan A López, Blanca Boluda, Rebeca Rodríguez-Veiga, Joaquin Martinez Lopez, Eva Barragán, Miguel Angel Sanz, Pau Montesinos, null On Behalf Of The Pethema Group
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3 -ITD Mutation-Positive Acute Myeloid Leukemia. Cancers 14 (11) (2022)
Camilla Guerrero, Noemi Puig, María-Teresa Cedena, Ibai Goicoechea, Cristina Perez, Juan-José Garcés, Cirino Botta, María-José Calasanz, Norma C Gutierrez, Maria-Luisa Martin-Ramos, Albert Oriol, Rafael Rios-Tamayo, Miguel-Teodoro Hernandez, Rafael Martinez-Martinez, Joan Bargay, Felipe De Arriba, Luis Palomera, Ana Pilar Gonzalez-Rodriguez, Adrian Mosquera-Orgueira, Marta-Sonia Gonzalez-Perez, Joaquin Martinez-Lopez, Juan-José Lahuerta, Laura Rosinol, Joan Blade, Maria-Victoria Mateos, Jesus F San-Miguel, Bruno Paiva
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Roser Vilarrasa-Blasi, Núria Verdaguer-Dot, Laura Belver, Paula Soler-Vila, Renée Beekman, Vicente Chapaprieta, Marta Kulis, Ana C Queirós, Maribel Parra, María-José Calasanz, Xabier Agirre, Felipe Prosper, Sílvia Beà, Dolors Colomer, Marc A Marti-Renom, Adolfo A Ferrando, Elias Campo, José Ignacio Martin-Subero
Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma. Leukemia (2021)
Noemi Puig, Miguel-Teodoro T Hernandez Garcia, Laura Rosiñol, Esther González, Felipe de Arriba, Albert Ortiol, Verónica González-Calle, Fernando Escalante, Javier de la Rubia, Mercedes Gironella, Rafael Ríos, Ricarda García-Sánchez, José M Arguiñano, Adrián Alegre, Jesús Martín-Sánchez, Norma C Gutiérrez, María-José Calasanz, María L Martín, María Del Carmen Couto, María Casanova, Mario Arnao, Ernesto Pérez-Persona, Sebastián Garzón, Marta S González, Guillermo Martín-Sánchez, Enrique M Ocio, Morton Coleman, Cristina Encinas, Ana M Vale, Ana I Teruel, María Cortés-Rodríguez, Juan José Lahuerta, M Teresa Cedena, Jesús San F Miguel, Juan-José Lahuerta, Joan Bladé, Ruben Niesvizky, Maria-Victoria Mateos-Manteca
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial. Blood cancer journal 11 (5) (2021)
Arantxa Carrasco-Leon, Teresa Ezponda, Cem Meydan, Luis Vitores Valcárcel, Raquel Ordoñez, Marta Kulis, Leire Garate, Estíbaliz Miranda, Victor Segura, Elisabeth Guruceaga, Amaia Vilas-Zornoza, Diego Alignani, Marién Pascual, Ane Amundarain, Laura Castro-Labrador, Patxi San Martín-Uriz, Halima El-Omri, Ruba Y Taha, María-José Calasanz, Francisco J Planes, Juan José Lahuerta, Christopher E Mason, Jesús San F Miguel, José Ignacio Martin-Subero, Ari M Melnick, Felipe Prosper, Xabier Agirre
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia 35 (5) (2021)
Paula Aguirre-Ruiz, Beñat Ariceta, María Cruz Viguria, María Teresa Zudaire, Zuriñe Blasco-Iturri, Patricia Arnedo, Almudena Aguilera-Diaz, Axier Jauregui, Amagoia Mañú, Felipe Prosper, María Carmen Mateos, Marta Fernández-Mercado, María José Larráyoz, Margarita Redondo, María-José Calasanz, Iria Vazquez, Eva Bandres
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms. Journal of clinical medicine 9 (12) (2020)
Alejandro Medina Herrera, Cristina Jiménez, M Eugenia Sarasquete, Marcos González, M Carmen Chillón, Ana Balanzategui, María Isabel Prieto-Conde, María García-Álvarez, Noemí Puig, Verónica González-Calle, Miguel Alcoceba, Isabel Cuenca, Santiago Barrio, Fernando Escalante, Norma C Gutiérrez, Mercedes Gironella, Miguel T Hernández, Anna Sureda, Albert Oriol, Joan Bladé, Juan-José Lahuerta, Jesús F San Miguel, Maria-Victoria Mateos-Manteca, Joaquín Martínez-López, María-José Calasanz, Miriam Santero
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients. Blood cancer journal 10 (2) (2020)